News and blogs
393 results found.
How is the coronarvirus affecting the blood cancer community’s mental health?
In the current climate, it’s inevitable that many people’s mental health will be affected to some extent as we’re cooped up inside and cut off from friends and family. But what impact has the coronavirus pandemic had on people affected by blood cancer specifically?
From Dine Out to Dine IN – Confessions of a Technophobe
Technophobe Maria Clarke from our Glasgow and District Branch hosts a successful virtual fundraiser.
Findings from our survey on COVID-19
Discover the findings from the Blood Cancer UK COVID-19 survey of people with blood cancer and those supporting them.
Over a third of people with blood cancer “haven’t had shielding letter”
Our survey found that over a third of people with blood cancer who are expecting to get a letter telling them to stay at home and shield because of the coronavirus have not yet received one.
People with undiagnosed blood cancer don't know they're vulnerable to coronavirus
There are over 10,000 people with undiagnosed blood cancer who are extremely vulnerable to the coronavirus, but don't know it.
Could a blood cancer drug be used to help people with COVID-19?
Calquence is being trialled in patients with COVID-19 who are critically ill, in the hope that it may reduce damage to their lungs.
Five charities call for supermarkets to sign up to key pledges
We've written to supermarkets with six key pledges, to ensure people with blood cancer and other vulnerable people shielding for 12 weeks can get food deliveries.
Call for supermarkets to prioritise people with blood cancer for online orders
We've written to the government and six major supermarkets, calling on them to take urgent action to make sure people with blood cancer can get food deliveries.
It's not a big day today, but it's been a big couple of years - Gemma Peters
When I joined this organisation, I said we never would change our name, writes our CEO Gemma Peters
Our new name
As of today, we have changed our name from Bloodwise to Blood Cancer UK.
Charities keep people well - we need government help too
The coronavirus emergency has increased demand for the third sector, while crushing its ability to raise funds, writes our CEO Gemma Peters.
Leukaemia protective role of Y chromosome gene discovered
Scientists funded by Blood Cancer UK have discovered the first leukaemia protective gene that is specific to the male-only Y chromosome.
Leukaemia - how we can use information to treat it
Why finding about how we get leukaemia in the first place is so important for developing new treatments.
How does the immune system destroy Hodgkin lymphoma?
In Hodgkin lymphoma, the cells which are the root cause of the cancer are hidden within a much larger number of white blood cells.
Researchers say blood cancer beaten in a few decades
Blood cancer researchers are excited about the future and say the scientific progress made mean blood cancer can be beaten in the next few decades.
Blood cancer treatment - weapon of war
As we pay tribute to the soldiers of World War I, we look at the surprising link between the battlefields of France and blood cancer research.
Lymphoma: new tool fights most dangerous
UK scientists funded by Bloodwise have found a new way to identify people with lymphoma who are less likely to respond to standard drugs.
The American Society of Haematology (ASH) Annual Meeting saw 30,000 experts to discuss new research examining blood cancers and other blood disorders.
The American Society of Haematology (ASH) Annual Meeting saw 30,000 experts to discuss new research examining blood cancers and other blood disorders.
Simon Thomas takes on president role
TV presenter Simon Thomas has announced that he has been made a President at Blood Cancer UK.
Simon Thomas is helping to beat blood cancer
Simon Thomas launched the Gemma Thomas Fund in memory of his wife, who lived with acute myeloid leukaemia (AML).